Related Experiment Video
Updated: Aug 23, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Effects of chronic nitric oxide inhibition on the renal excretory response to leptin
Daniel Villarreal1, Garry Reams, Huma Samar
1Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA. Villarrd@upstate.ed
Objective:
Previous investigations have demonstrated that leptin promotes natriuresis with a renal tubular effect. However, the mechanisms involved in this response are unclear. The present study was designed to examine the hypothesis that the natriuretic response to leptin in normotensive Sprague-Dawley rats is regulated by nitric oxide (NO).
Research Methods And Procedures:
The hemodynamic and renal excretory effects of intravenous bolus administration of pharmacological doses of synthetic murine leptin were examined in groups of control Sprague-Dawley rats (n = 8), Sprague-Dawley rats treated for 4 days with the NO synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) (n = 8), and Sprague-Dawley rats treated for 4 days with L-NAME followed by acute treatment with sodium nitroprusside (n = 8).
Results:
In the control group (n = 8), an intravenous bolus of leptin, 400 microg/kg body weight, increased urinary sodium excretion 4- to 6-fold. In the Sprague-Dawley rats chronically administered l-NAME (n = 8), an intravenous bolus of 400 microg/kg of leptin did not increase sodium excretion. Acute sodium nitroprusside infusion to Sprague-Dawley rats chronically treated with L-NAME (n = 8) was associated with partial restoration of the sodium excretory response to leptin administration.
Discussion:
Collectively, these results are interpreted to suggest that the natriuretic and diuretic responses to leptin observed in the Sprague-Dawley rat require a functional NO system.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Diabetic Nephropathy
Antihypertensive Drugs: Direct Renin Inhibitors

